Events shaping the global pharmaceutical industry provide an unprecedented opportunity for the least developed countries (LDCs) to attract investment in the pharmaceutical sector, including from other developing countries, a new UNCTAD report contends. With the right set of policies in place, LDCs can use the local production of pharmaceuticals to help ensure greater access to essential medicines, the study says.​